CN103536842A - Mixture for treating psoriasis - Google Patents

Mixture for treating psoriasis Download PDF

Info

Publication number
CN103536842A
CN103536842A CN201310197378.0A CN201310197378A CN103536842A CN 103536842 A CN103536842 A CN 103536842A CN 201310197378 A CN201310197378 A CN 201310197378A CN 103536842 A CN103536842 A CN 103536842A
Authority
CN
China
Prior art keywords
parts
radix
herba
mixture
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201310197378.0A
Other languages
Chinese (zh)
Inventor
吴娟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou Guli Biotechnology Co Ltd
Original Assignee
Suzhou Guli Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suzhou Guli Biotechnology Co Ltd filed Critical Suzhou Guli Biotechnology Co Ltd
Priority to CN201310197378.0A priority Critical patent/CN103536842A/en
Publication of CN103536842A publication Critical patent/CN103536842A/en
Withdrawn legal-status Critical Current

Links

Abstract

The invention discloses a mixture for treating psoriasis. The mixture comprises vinegar spring bupleurum, Chinese trumpet creeper, polygonum cuspidatum, gypsum, lithospermum, poria, peony tree root bark, dandelion, honeysuckle stem, duckweed, calcined oyster shell, stiff silkworm, red peony root, raw rehmannia, cortex dictamni, coix seed, ramulus euonyrni, cassia twig, liquorice, safflower, rhizoma anemarrhenae, curcuma zedoary and radix ophiopogonis. The mixture has the effects of eliminating diseases of patients, promoting physical and psychological health, and has outstanding substantial characteristics of low treatment cost, convenience in patient administration, quick curative effect, no side effect, as well as remarkable progress in treating psoriasis.

Description

A kind ofly be used for the treatment of psoriatic mixture
Technical field
The invention belongs to Chinese medicine technical field, relate to a kind of middle mixture, be specifically related to a kind of technical field that is used for the treatment of psoriatic mixture.
Background technology
Psoriasis at the initial stage of a disease, patient's erythra be hatpin head to inflammatory pimple or the maculopapule of Semen Glycines size, be pale red, pimple can expand gradually or merge form mutually speckle, boundary is clear, periphery has slight blush.Psoriasis is the extremely strong obstinate scytitis of a kind of recurrent, will bring the stress of load-bearing to patient after ill.
Current conventional therapy can only reach short-term effect, and has certain side effect.And because doctor trained in Western medicine it be unclear that psoriatic pathogenic factor and mechanism, therefore lack highly effective radical cure way.Chinese medicine, having long history and rich experience aspect treatment psoriasis, maintains.Therefore, seek a kind of illness new, that can eliminate patient, have take medicine conveniently, curative effect is fast, the psoriatic Traditional Chinese drug mixture that is used for the treatment of that have no side effect is still those skilled in the art's problem urgently to be resolved hurrily.
Summary of the invention
goal of the invention:the present invention, for solving the problems of the technologies described above, provides a kind of psoriatic mixture that is used for the treatment of.
technical scheme:for solving the problems of the technologies described above, the present invention adopts following technical scheme: be a kind ofly used for the treatment of psoriatic mixture, it is characterized in that the ingredients by following weight portion: vinegar HERBA BUPLEURL 10-40 part, Flos Campsis 5-20 part, Rhizoma Polygoni Cuspidati 10-40 part, Gypsum Fibrosum 15-45 part, Radix Arnebiae (Radix Lithospermi) 15-45 part, Poria 10-40 part, Cortex Moutan 15-45 part, Herba Taraxaci 15-50 part, Caulis Lonicerae 10-30 part, Herba Spirodelae 10-40 part, Concha Ostreae (calcined) 10-40 part, Bombyx Batryticatus 10-40 part, Radix Paeoniae Rubra 10-40 part, Radix Rehmanniae 10-40 part, Cortex Dictamni 20-60 part, Semen Coicis 20-60 part, Ramulus Euonymi 5-30 part, Ramulus Cinnamomi 10-40 part, Radix Glycyrrhizae 5-20 part, Flos Carthami 5-15 part, Rhizoma Anemarrhenae 10-30 part, Rhizoma Curcumae 10-40 part, Radix Ophiopogonis 10-30 part.
For further solving the problems of the technologies described above, the preferred version of said medicine weight portion is: vinegar HERBA BUPLEURL 20-30 part, Flos Campsis 10-15 part, Rhizoma Polygoni Cuspidati 20-30 part, Gypsum Fibrosum 25-35 part, Radix Arnebiae (Radix Lithospermi) 25-35 part, Poria 20-30 part, Cortex Moutan 25-35 part, Herba Taraxaci 20-45 part, Caulis Lonicerae 15-25 part, Herba Spirodelae 20-30 part, Concha Ostreae (calcined) 20-30 part, Bombyx Batryticatus 20-30 part, Radix Paeoniae Rubra 20-30 part, Radix Rehmanniae 20-30 part, Cortex Dictamni 30-50 part, Semen Coicis 30-50 part, Ramulus Euonymi 10-20 part, Ramulus Cinnamomi 20-30 part, Radix Glycyrrhizae 10-15 part, Flos Carthami 5-10 part, Rhizoma Anemarrhenae 15-30 part, Rhizoma Curcumae 15-40 part, Radix Ophiopogonis 15-30 part.
For further solving the problems of the technologies described above, the preferred plan of said medicine weight portion is: 25 parts of vinegar HERBA BUPLEURLs, 15 parts of Flos Campsiss, 25 parts of Rhizoma Polygoni Cuspidati, 30 parts of Gypsum Fibrosum, 30 parts of Radix Arnebiae (Radix Lithospermi)s, 25 parts, Poria, 30 parts of Cortex Moutans, 40 parts of Herba Taraxacis, 20 parts of Caulis Loniceraes, 25 parts, Herba Spirodelae, 25 parts of Concha Ostreae (calcined)s, 25 parts of Bombyx Batryticatus, 25 parts of Radix Paeoniae Rubra, 25 parts, the Radix Rehmanniae, 40 parts of Cortex Dictamnis, 40 parts of Semen Coicis, 15 parts of Ramulus Euonymis, 25 parts of Ramulus Cinnamomi, 12 parts, Radix Glycyrrhizae, 15 parts, Flos Carthami, 20 parts of the Rhizoma Anemarrhenaes, 30 parts of Rhizoma Curcumae, 20 parts of Radix Ophiopogonis.
Mixture described above according to the conventional technology of preparing of Chinese medicine make pill, sublimed preparation, powder, tablet, unguentum,
Decoction and the different oral medicine dosage form of capsule dress powder.
Traditional Chinese drug mixture described above also contains drug excipient.
Mixture described above is for the application as treatment psoriasis disease.
The principles of formulating prescriptions of mixture of the present invention are: with regulating blood flow circulation, clearing away heart-fire, expelling wind and removing dampness, kidney tonifying removing toxic substances, town pain are antipruritic, cooling blood and dissolving purpura, enhancement telangiectasis, improve immune function of human body, thereby reach the psoriatic object for the treatment of.The present invention has that compatibility of drugs is proper, reasonable recipe, according to the Chinese medicine of the configurable various dose of difference of the course of disease; Formula is novel, and drug effect is complementary, with low cost, psoriasis is had to good therapeutic effect, and have no side effect.
beneficial effect:traditional Chinese drug mixture result in clinical application of the present invention shows, tool has the following advantages:
1, the Traditional Chinese drug mixture each component that the present invention selects meets the regulation of the Drug Administration Law of People's Republic of China, utilizes comprehensive function treatment and the prevention psoriasis disease of each taste Chinese medicine, nontoxic to human body.Acute toxicity test and accumulation toxicity test through white mice and rat show that underproof animal has no any toxic reaction, through anatomic observation hemogram, liver function, each organs and tissues morphology finding and matched group, compare zero difference, prove that its safety of medicine is reliable.
2, Traditional Chinese drug mixture preparation of the present invention need not decoct, without bitterness sense, rich in proteins, grape sugar, glucuronic acid, volatile oil, pectin, fructose, organic acid, lecithin, vitamin, aminoacid in medicine, also containing various trace elements such as Saponin, plant sterol, calcium, be conducive to absorption of human body, health invigorating, and taking convenience.
3, Traditional Chinese drug mixture preparation of the present invention not only can effectively be treated psoriasis disease, and also very obvious to the preventive effect of psoriasis disease, particularly by mutually working in coordination with between medicine, strengthen medicine and treat separately characteristic, by dredge the meridian passage and adjusting immunologic function, the healthy energy and physical and mental health and the life quality that have improved patient body inherence, reach healing rehabilitation efficacy preferably.
Below by clinical practice, further illustrate Traditional Chinese drug mixture of the present invention to treating psoriatic effect.
One, clinical criteria:
The position of morbidity is the most common with scalp, is secondly shank, ancon, back, upper arm, forearm knee, chest and abdominal part and buttocks etc.Often be symmetry and distribute, also can distribute and be the linear alignment along tegumentary nerve.Skin lesion is from the beginning of for there being the flat pimple of polygon of assembling tendency, the normal or flushing slightly of color of the leather, lustrous surface or be covered with poor bran skin shape squama; owing to constantly scratching or rubbing, pimple expands gradually later, merges mutually in flakes; then local skin thickens, and texture is deepened, and intermeshes; dry tack free is coarse; and have a little canescence squama, and and being lichenification, skin lesion can rounded or irregular shape patch; clear border, that touches is coarse.Owing to scratching, affected part and around can be with scratch, petechia or blood crusts, also can have new flat hillock rash to occur near it.Conscious paroxysmal is very itched, more acute during by clothing friction and sweat stain, becoming severe at night, and that scratches does not know pain.During anxious state of mind, pruritus is aggravation thereupon also.Because pruritus can affect work and rest, patient is often with insomnia, dizzy, irritated symptom.The primary disease course of disease is slow, and constant year does not heal, repeatedly outbreak.
By its site of pathological change, skin lesion, how much be divided into two kinds of general hair style and topical types clinically.Topical type, skin lesion is detected in the parts such as neck, is the minority boundary plump speckle sheet of lichen sample clearly; General hair style, distributed more widely general, be apt to occur in head, extremity, shoulder waist etc. and locate, everywhere, skin lesion feature is identical with topical type for an even general whole body.
According to psoriatic clinical manifestation and pathological characters, be generally divided into following Four types
1, psoriasis vulgaris: erythra generally occurs in scalp, trunk, extremity and stretches side, on skin, to occur red pimple, and expand and be fused into patch or speckle gradually, there are thicker silvery white phosphorus bits on surface, out-of-shape, what have has map or an island sample outward appearance, some skin lesion are less, more, are Caulis et folium pavettae hongkongensis outward appearance, squama layer one deck comes off, wipe gently scurf off and can see the red film of very thin one deck, strike off red film and can see slight petechia, have person for blood dew, medically make again sieve shape hemorrhage, homeliness type psoriasis Clinical symptoms that Here it is.
2, erythrodermic psoriasis: be more serious, more rare is a kind of, this kind of refers to and more than 70% is diffusivity redness at about whole skin, kermesinus wellability skin lesion, there are a large amount of bran skin sample scurfs on surface, sometimes in oxter, thigh root and umbilical part make exfoliation and oozing out because of swelling, oropharynx nose and eye conjunctiva can be congested rubescent, and patient often has heating fear of cold, the symptoms such as headache and general malaise.
3, pustular psoriasis: divide general property and limitation.General property pustule type psoriasis mostly is acute onset, can be within a few days to several weeks general whole body of pustule, first there is the intensive potential pimple of needle point size, be fused into very soon pus lake, often, with high heat, arthralgia and general malaise, routine blood test is chemically examined visible leukocytosis, after abscess is dry, desquamation, after scurf comes off, has again new abscess to occur immediately.Limitation pustule type psoriasis is common with palm toe pustule type psoriasis, at the both hands palms and toes portion, there is symmetry erythema, in erythema, occur that syringe needle arrive greatly Li great little to pimple: about 1-2 dries up after week voluntarily, has again new pustule appearance after desquamation, repeatedly be continuous, the course of disease is obstinate.
4, psoriasis arthropathica: rarely found, any age all can occur can betide big or small joint simultaneously, but common be the little joint of wrist, finger and toes, joint of vertebral column also can occur.The joint of pathological changes has redness, pain, serious articular cavity to have hydrops, juxtra-articular skin turgor limitation of activity, joint stiffness of a specified duration, the destroyed situation in visible joint under x-ray when serious, erythrocyte sedimentation rate is fast, the General Symptomies such as heat that often occur together, but rheumatoid agglutinating factor is negative, psoriasis arthropathica, skin lesion, how with the ostraceous skin lesion of thick picture, also can only have the skin lesion of the psoriasic erythema of homeliness type and silver bits.
Differential Diagnosis
1. chronic eczema has erubescence, pimple, vesicle, erosion more, the pathogenic process of acute eczema such as oozes out, and it is coarse as main that skin lesion be take plumpness, and with eruption, vesicle, erosion, ooze out, owe clearly on border, and pathological changes is many bends side at extremity.
2. skin amyloidosis is multiple stretches side at back and shank, and skin is the dome pimple of sorghum rice size, and color is purple brown, and matter is harder, in groups intensive, and keratinization is coarse.
3. white lump skin lesion substrate is pale red, upper coated with silvery white pityrosporum shape squama, has thin film phenomenon and petechial hemorrhage after peelling off.
Two. the selection of case
For the patient who meets above-mentioned disease, all can be used as case and observe, especially weak and sickly, middle-aged and elderly people, women, child are observed as first-selected case especially; The method of observing is carried out complete observation by the method for hoping, asking, hearing, cutting to patient; And, sex of all ages for the heavier patient of the state of an illness, without exception as the direct study subject of observing treatment.
Three. administrated method
According to the length of psoriatic's severe extent, sick time, adopt interior with oral of the present invention
Traditional Chinese drug mixture is treated psoriasis, and its method of administration is: three times on the one, and each 6-12 gram, warm water delivery service; Ante cibum, one after each meal all can.The phase that just takes is 30 days, and dose can increase doubly, and after this dose is taken medicine continuously routinely, within three months, is to observe a course for the treatment of and curative effect judgement.Traditional Chinese drug mixture of the present invention is because of Chinese medicine preparation, reasonable recipe, through clinical application toxicity test proof, have no side effect, therefore, patient can take Chinese patent medicine of the present invention the long period during treating, and aspect period in a medicine diet without dieting.
Four. curative effect determinate standard
Because psoriasis is for easily examining the dermatosis of refractory, thereby psoriatic clinical treatment observation index and curative effect judgement mark
Standard is divided into: during treatment, treatment finish after and visit long term in three periods.
1. treat phase clinical observation and curative effect judging standard
(1) clinical observation
1. squama: the propagation of epidermis cell is accelerated and hyperacanthosis, causes cuticular hyperkeratosis, makes epidermis renew the fast 7-8 of rate compared with normal epidermis doubly, every 3 days left and right desquamation one decks.Criterion after medication is: squama reduces gradually or appears as effectively without new skin lesion, otherwise is invalid.
2. substrate: it shows as substrate infiltration, plumpness, shows that the stratum germinativum increment of chrotoplast slows down, and hyperacanthosis fades, and substrate skin lesion, by thick attenuation, illustrate effectively, and substrate infiltrates without changing, and plump without attenuation, it is invalid to illustrate.
3. color: due to the expansion of corium superficial part vascular plexus and blood capillary, its skin lesion has the non-fading red appearance of pressure more.After medication, along with the alleviation of the state of an illness, the color of erythra is also light red by red stain, illustrates effectively, otherwise is invalid.
4. scope: skin lesion many and few, indicate the light and heavy of the state of an illness.After medication, new skin lesion stops appearance, and original erythra starts to dwindle from edge, or therefrom mind-set edge disappears gradually, and the erythra that part is large is divided into some fritters, illustrate effectively, on the contrary invalid.
(2) curative effect judging standard:
1. effective: in above four, there are three to be clearly better, or four improvement that all have in various degree; Or binomial disappearance, another binomial improves.
2. effective: to have binomial to improve or a disappearance.
3. invalid: through one course for the treatment of of clinical application, skin lesion is without improving or increasing the weight of.
2. treatment finishes rear clinical observation and curative effect judging standard
(1) clinical observation:
1. squama: observe and whether have new squama to occur.
2. substrate: whether erythra calms down, the smoothness of skin.
3. color: observe and have or not pigmentation or depigmentation.
4. scope: observe and whether have new erythra to occur and the situation that disappears of former skin lesion.
(2) curative effect judging standard:
1. clinical cure: skin lesion all disappears, only leaves pigmentation or de-mistake.
2. effective: skin lesion disappears more than 70%.
3. effective: skin lesion disappears between 30-70%.
4. invalid: skin lesion disappears below 30% or do not controlled on the contrary and increase the weight of.
3. visit clinical observation and curative effect judging standard long term
(1) clinical observation:
1. time: treatment finishes rear more than 1 year or 2~tri-years, visit recovery from illness and recurrence.
2. case: visit case and cause of recurrence that observation post cures.
(2) curative effect judging standard:
1. recurrence: expand or increase the weight of before the treatment of skin lesion Area Ratio.
2. gently recurrence: recurrence skin lesion is former skin lesion below 50%.
Five. clinical treatment result
Traditional Chinese drug mixture of the present invention, through all kinds of psoriatics 278 examples of accepting for medical treatment altogether in 2,008 one 2012 4 years are carried out to orally taken for curing, male's 146 examples wherein, women's 132 examples, the age is 14-60 year; Its clinical treatment result, according to above-mentioned domestic unified criterion of therapeutical effect statistical computation is: recovery from illness (3 years recidivists not are above observed in drug withdrawal) 110 examples, and cure rate is 39.57%; Effective (1 year recidivist not is above observed in drug withdrawal) 96 examples, obvious effective rate is 34.53%; Effective (symptom obviously alleviates scurf major part and comes off, and still has the small part silver bits person of not moving back) 54 examples, effective percentage is 19.42%; Invalid (take medicine 2 courses for the treatment of not alleviator) 18 examples, inefficiency 6.47%; Total effective rate is 93.53%, there are no any toxic and side effects.
Model case is introduced:
1, woods X, man, 35 years old, live Yangzhou Hanjiang District, Jiangsu Province, on February 7th, 2009 goes to a doctor in the applicant's out-patient department, according to ill 6 years of patient's readme, repeatedly goes to see a doctor, and all without positive effect, does not cure so far.Through taking Traditional Chinese drug mixture of the present invention after the course for the treatment of, disease significant effective, after this continuous use fully recovers 9 courses for the treatment of.Treatment finishes to visit above for latter 2 years not recurrence.
2, turn round and look at X, man, 38 years old, live Licheng District, Quanzhou City, Fujian Province, suffer from psoriasis nearly 12 years, through others, be illustrated in and go to a doctor in the applicant's out-patient department on May 12nd, 2008, since patient's readme is ill, repeatedly gone to see a doctor, also used others to folk prescription, bad during fashion, all without positive effect, do not cure so far.Take afterwards after diagnosing Traditional Chinese drug mixture of the present invention after the course for the treatment of, disease has no positive effect, but sensation effectively; Patient after this 3 course for the treatment of sides of continuous use sees obvious curative effects; Continuing to take Traditional Chinese drug mixture of the present invention fully recovers 10 courses for the treatment of.After finishing, treatment within 3 years, visited above so far not recurrence.
3, Liu X, female, 31 years old, lives Jianshan District, Shuangyashan City, Heilongjiang Province, suffer from psoriasis nearly 10 years, through others, be illustrated in and go to a doctor in the applicant's out-patient department on April 13rd, 2009, patient has repeatedly gone to see a doctor since ill, also used others to folk prescription, bad during fashion, but do not cure so far.Take afterwards after diagnosing Traditional Chinese drug mixture of the present invention after the course for the treatment of, the visible positive effect of disease; Patient after this continuous use fully recovers 6 courses for the treatment of.After finishing, treatment within 2 years, visited above so far not recurrence.
The specific embodiment
Embodiment 1
Traditional Chinese drug mixture described in the present embodiment is to press row weight portion to take each Chinese crude drug: 10 parts of vinegar HERBA BUPLEURLs, 15 parts of Flos Campsiss, 10 parts of Rhizoma Polygoni Cuspidati, 15 parts of Gypsum Fibrosum, 15 parts of Radix Arnebiae (Radix Lithospermi)s, 10 parts, Poria, 15 parts of Cortex Moutans, 35 parts of Herba Taraxacis, 18 parts of Caulis Loniceraes, 10 parts, Herba Spirodelae, 10 parts of Concha Ostreae (calcined)s, 20 parts of Bombyx Batryticatus, 10 parts of Radix Paeoniae Rubra, 10 parts, the Radix Rehmanniae, 20 parts of Cortex Dictamnis, 20 parts of Semen Coicis, 25 parts of Ramulus Euonymis, 10 parts of Ramulus Cinnamomi, 5 parts, Radix Glycyrrhizae, 15 parts, Flos Carthami, 10 parts of the Rhizoma Anemarrhenaes, 35 parts of Rhizoma Curcumae, 20 parts of Radix Ophiopogonis.
Traditional Chinese drug mixture described in the present embodiment is that its preparation technology is: the pharmaceutical methods that above-mentioned each medicinal raw material is prepared to sublimed preparation according to routine is made sublimed preparation as the psoriatic endo-medicine for the treatment of.
Embodiment 2
Press row weight portion and take each medical material: 40 parts of vinegar HERBA BUPLEURLs, 10 parts of Flos Campsiss, 40 parts of Rhizoma Polygoni Cuspidati, 45 parts of Gypsum Fibrosum, 45 parts of Radix Arnebiae (Radix Lithospermi)s, 40 parts, Poria, 45 parts of Cortex Moutans, 45 parts of Herba Taraxacis, 15 parts of Caulis Loniceraes, 40 parts, Herba Spirodelae, 40 parts of Concha Ostreae (calcined)s, 20 parts of Bombyx Batryticatus, 40 parts of Radix Paeoniae Rubra, 40 parts, the Radix Rehmanniae, 60 parts of Cortex Dictamnis, 60 parts of Semen Coicis, 20 parts of Ramulus Euonymis, 40 parts of Ramulus Cinnamomi, 20 parts, Radix Glycyrrhizae, 10 parts, Flos Carthami, 30 parts of the Rhizoma Anemarrhenaes, 40 parts of Rhizoma Curcumae, 30 parts of Radix Ophiopogonis.
Traditional Chinese drug mixture described in the present embodiment is that its preparation technology is: the pharmaceutical methods that above-mentioned each medicinal raw material is prepared to powder according to routine is made packed powder as the psoriatic endo-medicine for the treatment of.
Embodiment 3
Press row weight portion and take each medical material: 20 parts of vinegar HERBA BUPLEURLs, 20 parts of Flos Campsiss, 20 parts of Rhizoma Polygoni Cuspidati, 25 parts of Gypsum Fibrosum, 25 parts of Radix Arnebiae (Radix Lithospermi)s, 20 parts, Poria, 25 parts of Cortex Moutans, 45 parts of Herba Taraxacis, 20 parts of Caulis Loniceraes, 20 parts, Herba Spirodelae, 20 parts of Concha Ostreae (calcined)s, 25 parts of Bombyx Batryticatus, 20 parts of Radix Paeoniae Rubra, 20 parts, the Radix Rehmanniae, 30 parts of Cortex Dictamnis, 30 parts of Semen Coicis, 25 parts of Ramulus Euonymis, 20 parts of Ramulus Cinnamomi, 10 parts, Radix Glycyrrhizae, 15 parts, Flos Carthami, 25 parts of the Rhizoma Anemarrhenaes, 35 parts of Rhizoma Curcumae, 25 parts of Radix Ophiopogonis.
Traditional Chinese drug mixture described in the present embodiment is that its preparation technology is: the pharmaceutical methods that above-mentioned each medicinal raw material is prepared to capsule according to routine is made capsule as the psoriatic endo-medicine for the treatment of.
Embodiment 4
Press row weight portion and take each medical material: 30 parts of vinegar HERBA BUPLEURLs, 15 parts of Flos Campsiss, 30 parts of Rhizoma Polygoni Cuspidati, 35 parts of Gypsum Fibrosum, 35 parts of Radix Arnebiae (Radix Lithospermi)s, 30 parts, Poria, 35 parts of Cortex Moutans, 35 parts of Herba Taraxacis, 25 parts of Caulis Loniceraes, 30 parts, Herba Spirodelae, 30 parts of Concha Ostreae (calcined)s, 30 parts of Bombyx Batryticatus, 30 parts of Radix Paeoniae Rubra, 30 parts, the Radix Rehmanniae, 50 parts of Cortex Dictamnis, 50 parts of Semen Coicis, 30 parts of Ramulus Euonymis, 30 parts of Ramulus Cinnamomi, 15 parts, Radix Glycyrrhizae, 10 parts, Flos Carthami, 30 parts of the Rhizoma Anemarrhenaes, 40 parts of Rhizoma Curcumae, 35 parts of Radix Ophiopogonis.
Traditional Chinese drug mixture described in the present embodiment is as the psoriatic endo-medicine for the treatment of, its preparation technology is: the pharmaceutical methods that above-mentioned each medicinal raw material is prepared to tablet according to routine is made tablet, (as conventional tablet, sugar coated tablet, film coated tablet etc.), and give conventional drug excipient (as starch, sucrose, lactose, calcium stearate, magnesium stearate etc.).
Embodiment 5
Press row weight portion and take each medical material: 25 parts of vinegar HERBA BUPLEURLs, 20 parts of Flos Campsiss, 25 parts of Rhizoma Polygoni Cuspidati, 30 parts of Gypsum Fibrosum, 30 parts of Radix Arnebiae (Radix Lithospermi)s, 25 parts, Poria, 30 parts of Cortex Moutans, 40 parts of Herba Taraxacis, 25 parts of Caulis Loniceraes, 25 parts, Herba Spirodelae, 25 parts of Concha Ostreae (calcined)s, 25 parts of Bombyx Batryticatus, 25 parts of Radix Paeoniae Rubra, 25 parts, the Radix Rehmanniae, 40 parts of Cortex Dictamnis, 40 parts of Semen Coicis, 25 parts of Ramulus Euonymis, 25 parts of Ramulus Cinnamomi, 12 parts, Radix Glycyrrhizae, 10 parts, Flos Carthami, 25 parts of the Rhizoma Anemarrhenaes, 25 parts of Rhizoma Curcumae, 15 parts of Radix Ophiopogonis.
Traditional Chinese drug mixture described in the present embodiment is that its preparation technology is: the pharmaceutical methods that above-mentioned each medicinal raw material is prepared to pill according to routine is made pill, and gives conventional drug excipient as the psoriatic endo-medicine for the treatment of.
Embodiment 6
Press row weight portion and take each medical material: 15 parts of vinegar HERBA BUPLEURLs, 15 parts of Flos Campsiss, 15 parts of Rhizoma Polygoni Cuspidati, 30 parts of Gypsum Fibrosum, 30 parts of Radix Arnebiae (Radix Lithospermi)s, 15 parts, Poria, 30 parts of Cortex Moutans, 40 parts of Herba Taraxacis, 30 parts of Caulis Loniceraes, 15 parts, Herba Spirodelae, 15 parts of Concha Ostreae (calcined)s, 35 parts of Bombyx Batryticatus, 15 parts of Radix Paeoniae Rubra, 15 parts, the Radix Rehmanniae, 40 parts of Cortex Dictamnis, 40 parts of Semen Coicis, 15 parts of Ramulus Euonymis, 15 parts of Ramulus Cinnamomi, 12 parts, Radix Glycyrrhizae, 15 parts, Flos Carthami, 25 parts of the Rhizoma Anemarrhenaes, 25 parts of Rhizoma Curcumae, 30 parts of Radix Ophiopogonis.
Traditional Chinese drug mixture described in the present embodiment is that its preparation technology is: above-mentioned each medicinal raw material is prepared to the pharmaceutical methods granulation agent of granule according to routine as the psoriatic endo-medicine for the treatment of.

Claims (4)

1. one kind is used for the treatment of psoriatic mixture, it is characterized in that the ingredients by following weight portion: vinegar HERBA BUPLEURL 10-40 part, Flos Campsis 5-20 part, Rhizoma Polygoni Cuspidati 10-40 part, Gypsum Fibrosum 15-45 part, Radix Arnebiae (Radix Lithospermi) 15-45 part, Poria 10-40 part, Cortex Moutan 15-45 part, Herba Taraxaci 15-50 part, Caulis Lonicerae 10-30 part, Herba Spirodelae 10-40 part, Concha Ostreae (calcined) 10-40 part, Bombyx Batryticatus 10-40 part, Radix Paeoniae Rubra 10-40 part, Radix Rehmanniae 10-40 part, Cortex Dictamni 20-60 part, Semen Coicis 20-60 part, Ramulus Euonymi 5-30 part, Ramulus Cinnamomi 10-40 part, Radix Glycyrrhizae 5-20 part, Flos Carthami 5-15 part, Rhizoma Anemarrhenae 10-30 part, Rhizoma Curcumae 10-40 part, Radix Ophiopogonis 10-30 part.
2. be according to claim 1ly used for the treatment of psoriatic mixture, it is characterized in that the ingredients by following weight portion: vinegar HERBA BUPLEURL 20-30 part, Flos Campsis 10-15 part, Rhizoma Polygoni Cuspidati 20-30 part, Gypsum Fibrosum 25-35 part, Radix Arnebiae (Radix Lithospermi) 25-35 part, Poria 20-30 part, Cortex Moutan 25-35 part, Herba Taraxaci 20-45 part, Caulis Lonicerae 15-25 part, Herba Spirodelae 20-30 part, Concha Ostreae (calcined) 20-30 part, Bombyx Batryticatus 20-30 part, Radix Paeoniae Rubra 20-30 part, Radix Rehmanniae 20-30 part, Cortex Dictamni 30-50 part, Semen Coicis 30-50 part, Ramulus Euonymi 10-20 part, Ramulus Cinnamomi 20-30 part, Radix Glycyrrhizae 10-15 part, Flos Carthami 5-10 part, Rhizoma Anemarrhenae 15-30 part, Rhizoma Curcumae 15-40 part, Radix Ophiopogonis 15-30 part.
3. be according to claim 1ly used for the treatment of psoriatic mixture, it is characterized in that the ingredients by following weight portion: 25 parts of vinegar HERBA BUPLEURLs, 15 parts of Flos Campsiss, 25 parts of Rhizoma Polygoni Cuspidati, 30 parts of Gypsum Fibrosum, 30 parts of Radix Arnebiae (Radix Lithospermi)s, 25 parts, Poria, 30 parts of Cortex Moutans, 40 parts of Herba Taraxacis, 20 parts of Caulis Loniceraes, 25 parts, Herba Spirodelae, 25 parts of Concha Ostreae (calcined)s, 25 parts of Bombyx Batryticatus, 25 parts of Radix Paeoniae Rubra, 25 parts, the Radix Rehmanniae, 40 parts of Cortex Dictamnis, 40 parts of Semen Coicis, 15 parts of Ramulus Euonymis, 25 parts of Ramulus Cinnamomi, 12 parts, Radix Glycyrrhizae, 15 parts, Flos Carthami, 20 parts of the Rhizoma Anemarrhenaes, 30 parts of Rhizoma Curcumae, 20 parts of Radix Ophiopogonis.
4. according to pill, sublimed preparation, powder, tablet, unguentum, decoction and the capsule that psoriatic mixture is made that be used for the treatment of described in the arbitrary claim of claims 1 to 3.
CN201310197378.0A 2013-05-24 2013-05-24 Mixture for treating psoriasis Withdrawn CN103536842A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310197378.0A CN103536842A (en) 2013-05-24 2013-05-24 Mixture for treating psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310197378.0A CN103536842A (en) 2013-05-24 2013-05-24 Mixture for treating psoriasis

Publications (1)

Publication Number Publication Date
CN103536842A true CN103536842A (en) 2014-01-29

Family

ID=49960956

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310197378.0A Withdrawn CN103536842A (en) 2013-05-24 2013-05-24 Mixture for treating psoriasis

Country Status (1)

Country Link
CN (1) CN103536842A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104069281A (en) * 2014-07-23 2014-10-01 徐辉 Medicine for treating psoriasis
CN108295217A (en) * 2018-03-08 2018-07-20 山西忻州兴华皮肤病专科医院 A kind of Chinese medicine preparation for treating delay refractory psoriasis vulgaris

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102100862A (en) * 2011-01-30 2011-06-22 郭秀敏 Psoriasis-removing soup for treating psoriasis and method for preparing same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102100862A (en) * 2011-01-30 2011-06-22 郭秀敏 Psoriasis-removing soup for treating psoriasis and method for preparing same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
宋玉明等: "张吉辨证论治银屑病关节炎经验", 《中国中医药信息杂志》, 25 May 2009 (2009-05-25) *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104069281A (en) * 2014-07-23 2014-10-01 徐辉 Medicine for treating psoriasis
CN108295217A (en) * 2018-03-08 2018-07-20 山西忻州兴华皮肤病专科医院 A kind of Chinese medicine preparation for treating delay refractory psoriasis vulgaris

Similar Documents

Publication Publication Date Title
CN102406867A (en) Traditional Chinese medicine for treating psoriasis
CN101073575B (en) Capsule for treating acne
CN102406866A (en) Chinese medicinal composition for treating psoriasis
CN101897933B (en) Chinese patent medicament for treating leucoderma
CN102423433A (en) Traditional Chinese drug mixture for treating psoriasis
CN102579975B (en) Traditional Chinese medicine mixture for treating psoriasis
CN103536842A (en) Mixture for treating psoriasis
CN103251878B (en) Anti-fatigue traditional Chinese medicine composition
CN102641368B (en) A kind of Chinese medicine for the treatment of beriberi
CN102198202B (en) Pills for treating gout
CN104784538A (en) Chinese medicinal preparation for treating diabetes and preparation method
CN102579895B (en) Traditional Chinese medicine composition for treating psoriasis
CN102416117A (en) Chinese patent medicine for treating psoriasis
CN102406893A (en) Chinese patent medicine for treating psoriasis.
CN102406865A (en) Chinese medicinal composition for treating psoriasis
CN103356932A (en) Medicine composition for treating vulva squamous cell hyperplasia
CN103381246B (en) Traditional Chinese medicine for treating psoriasis
CN102416099A (en) Traditional Chinese medicine for treating psoriasis
CN102552824B (en) Traditional Chinese medicine prepared prescription for treating psoriasis
CN103272072B (en) Chinese medicinal composition for treating psoriasis
CN102423458A (en) Chinese patent medicine for treating psoriasis
CN1352959A (en) Chinese medicine for treating heart disease
CN101385836B (en) Traditional Chinese medicine composition containing poria cocos for treating dermatomyositis and preparation thereof
CN102416118A (en) Chinese medicinal composition for treating psoriasis
CN102228561B (en) Chinese patent medicine for treating pityriasis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
C04 Withdrawal of patent application after publication (patent law 2001)
WW01 Invention patent application withdrawn after publication

Application publication date: 20140129